From the Department of Surgical, Medical, Molecular Pathology and Critical Area, Unit of Endocrine Surgery, University Hospital of Pisa, Pisa, Italy; These authors contributed equally to the study.
Department of Clinical and Experimental Medicine, Unit of Endocrinology, University Hospital of Pisa, Pisa, Italy.
Endocr Pract. 2020 Aug;26(8):807-817. doi: 10.4158/EP-2019-0532.
Prophylactic central compartment lymph node dissection (pCCND) results in a higher percentage of surgical-related complications. To date, no evidence of the impact of pCCND on the clinical outcome of papillary thyroid carcinoma (PTC) patients with synchronous ipsilateral cervical lymph node metastases has been reported.
We evaluated all consecutive patients affected by PTC and synchronous ipsilateral cervical, but without evidence of central compartment, lymph node metastases. We selected 54 consecutive patients (group A) treated by total thyroidectomy, ipsilateral cervical lymph node dissection, and pCCND and 115 patients (group B) matched for sex, age at diagnosis, number and dimension of the metastatic lateral cervical lymph nodes, without pCCND. Clinical outcome after a median of 5 years and surgical-related complications were assessed.
The two groups were completely similar in terms of clinical features. Clinical outcomes showed a higher percentage of biochemical and indeterminate but not structural response in group B. Group B required significantly more radioiodine treatments, but no difference was shown in the need to repeat surgery for recurrences. Conversely, the prevalence of permanent hypoparathyroidism was significantly higher in group A (14.8%) than in group B (4.3%).
In PTC patients with synchronous ipsilateral cervical lymph node metastases, in absence of clinically evident lymph node metastases of the central compartment, performing pCCND does not improve the 5-year outcome in terms of structural disease, despite a greater number of I treatments. However, pCCND is severely affected by a higher percentage of permanent hypoparathyroidism, even in the hands of expert surgeons.
IQR = interquartile range; pCCND = prophylactic central compartment lymph node dissection; PTC = papillary thyroid carcinoma; Tg = thyroglobulin; US = ultrasound.
预防性中央区淋巴结清扫(pCCND)会导致更高比例的手术相关并发症。迄今为止,尚无证据表明 pCCND 对伴有同侧颈淋巴结转移的甲状腺乳头状癌(PTC)患者的临床结局有影响。
我们评估了所有患有 PTC 且同侧颈淋巴结转移、但无中央区淋巴结转移证据的连续患者。我们选择了 54 例连续患者(A 组),接受甲状腺全切除术、同侧颈淋巴结清扫术和 pCCND 治疗,以及 115 例(B 组)性别、诊断时年龄、转移性侧颈淋巴结数量和大小相匹配的患者,未行 pCCND。评估了中位数为 5 年后的临床结局和手术相关并发症。
两组在临床特征方面完全相似。临床结局显示,B 组生化和不确定缓解的比例更高,但结构缓解的比例无差异。B 组需要更多的放射性碘治疗,但重复手术治疗复发的需求无差异。相反,A 组(14.8%)永久性甲状旁腺功能减退症的患病率明显高于 B 组(4.3%)。
在伴有同侧颈淋巴结转移的 PTC 患者中,在无临床明显中央区淋巴结转移的情况下,行 pCCND 并不会改善 5 年结构疾病的结局,尽管 I 治疗的次数更多。然而,pCCND 会严重导致永久性甲状旁腺功能减退症的比例增加,即使是在经验丰富的外科医生手中。
IQR = 四分位距;pCCND = 预防性中央区淋巴结清扫;PTC = 甲状腺乳头状癌;Tg = 甲状腺球蛋白;US = 超声。